Profil bibliographique

Helen Millward

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

19Publications signalées

4170Citations signalées

1Affiliations récentes

Institutions déclarées

Acacia Pharma (United Kingdom)

Domaines associés

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19interferon and immune responsesDNA Repair Mechanisms

Publications récentes

2026 conference-abstractOpenAlex

Phase IIa, open-label, multi-center study of the DNA polymerase theta inhibitor ART6043 administered orally in combination with olaparib to patients with HER2-negative breast cancer with a germline BRCA1/2 mutation (randomized expansion of study NCT05898399).

Mark Robson, Timothy A. Yap, Gaorav P. Gupta, Raquel Andrés et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

STELLA: A dose expansion of the ATR kinase inhibitor alnodesertib (ART0380) administered orally in combination with low-dose irinotecan to patients with advanced or metastatic CRC and PDAC.

Kim Anna Reiss, Babar Bashir, Susanna V. Ulahannan, Katrina S. Pedersen et autres

0 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

Abstract CT267: First results of ART0380 (an ATR kinase inhibitor) with low dose irinotecan in advanced or metastatic solid tumors

Susanna V. Ulahannan, Jason T. Henry, Kathleen N. Moore, Gerald S. Falchook et autres

3 citationsCancer Research

2024 articleOpenAlex

A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST)

Carol Aghajanian, Christina Washington, Kathleen N. Moore, Thomas C. Krivak et autres

1 citationGynecologic Oncology

Accès ouvert 2024 articleOpenAlex

Stratified analyses refine association between TLR7 rare variants and severe COVID-19

Jannik Boos, Caspar I. van der Made, Gayatri Ramakrishnan, Eamon Coughlan et autres

12 citationsHuman Genetics and Genomics Advances

Accès ouvert 2023 articleOpenAlex

A second update on mapping the human genetic architecture of COVID-19

Shea J. Andrews, Mattia Cordioli, Christine Stevens, Mark J. Daly et autres

124 citationsNature

Accès ouvert 2023 erratumOpenAlex

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Erola Pairo‐Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi et autres

10 citationsNature

Accès ouvert 2023 articleOpenAlex

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Erola Pairo‐Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi et autres

231 citationsNature

Accès ouvert 2023 articleOpenAlex

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres

132 citationsThe Lancet

Accès ouvert 2022 articleOpenAlex

Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study

Edward Mullins, A. Perry, Jayanta Banerjee, Julia Townson et autres

69 citationsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology

Accès ouvert 2022 articleOpenAlex

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres

334 citationsThe Lancet

2022 conference-abstractOpenAlex

Abstract LB520: A pharmacodynamic platform using liquid biopsy to support dose selection for the ATR inhibitor ART0380 (IACS-030380)

Manish R. Patel, Kathleen N. Moore, Desirèe Piscitello, Jayesh B. Majithiya et autres

3 citationsCancer Research

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.